We are a pre-seed pharmaceutical start-up with a mission of creating therapeutics to allow traumatic brain injury patients to have a faster and fuller recovery. The founder, Lyeth, went through a brain tumor resection at the age of 13 for an astrocytoma brain tumor in his cerebellum. After the extensive and costly rehabilitation process, he is still not fully recovered. He set his life mission to easing the pain of others who are going through similar situations.